Get the Stockscreener App
4.83
1.90%
0.09
Pre-market:
4.75
-0.08
-1.66%
Atai Life Sciences N V stock is traded at $4.83, with a volume of 8.10M.
It is up +1.90% in the last 24 hours and up +35.29% over the past month.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.
See More
Previous Close:
$4.74
Open:
$4.78
24h Volume:
8.10M
Relative Volume:
1.44
Market Cap:
$967.63M
Revenue:
$314.00K
Net Income/Loss:
$-40.23M
P/E Ratio:
-17.25
EPS:
-0.28
Net Cash Flow:
$-84.71M
1W Performance:
+21.66%
1M Performance:
+35.29%
6M Performance:
+179.19%
1Y Performance:
+268.70%
1-Day Range:
$4.51
$5.01
1-Week Range:
$3.86
$5.34
52-Week Range:
$1.03
$5.34
Atai Life Sciences N V Stock (ATAI) Company Profile
Name
Atai Life Sciences N V
Sector
Industry
Phone
49 89 2153 9035
Address
PROF. J.H. BAVINCKLAAN 7, AMSTELVEEN
Compare ATAI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ATAI
Atai Life Sciences N V
|
4.83 | 868.07M | 314.00K | -40.23M | -84.71M | -0.28 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.18 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
587.65 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.20 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
708.09 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
308.91 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Atai Life Sciences N V Stock (ATAI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-29-25 | Initiated | Oppenheimer | Outperform |
| Nov-18-24 | Reiterated | H.C. Wainwright | Buy |
| Apr-03-24 | Upgrade | Maxim Group | Hold → Buy |
| Nov-01-22 | Initiated | Loop Capital | Buy |
| Nov-30-21 | Initiated | Maxim Group | Buy |
| Nov-11-21 | Initiated | ROTH Capital | Buy |
| Oct-18-21 | Initiated | H.C. Wainwright | Buy |
| Sep-01-21 | Initiated | Jefferies | Buy |
| Jul-13-21 | Initiated | Berenberg | Buy |
| Jul-13-21 | Initiated | Canaccord Genuity | Buy |
| Jul-13-21 | Initiated | Cantor Fitzgerald | Buy |
| Jul-13-21 | Initiated | Citigroup | Buy |
| Jul-13-21 | Initiated | Cowen | Outperform |
| Jul-13-21 | Initiated | Credit Suisse | Outperform |
| Jul-13-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Jul-08-21 | Initiated | Aegis Capital | Buy |
View All
Atai Life Sciences N V Stock (ATAI) Latest News
How to build a dashboard for Atai Life Sciences N.V. stockPortfolio Value Summary & AI Forecasted Entry and Exit Points - Newser
What the charts say about Atai Life Sciences N.V. todayQuarterly Growth Report & Daily Momentum Trading Reports - Newser
Using fundamentals and technicals on Atai Life Sciences N.V.Portfolio Value Report & Low Drawdown Investment Strategies - Newser
Smart tools for monitoring Atai Life Sciences N.V.’s price actionMarket Activity Summary & Accurate Entry/Exit Alerts - Newser
Risk vs reward if holding onto Atai Life Sciences N.V.Trend Reversal & Safe Entry Momentum Tips - Newser
Applying big data sentiment scoring on Atai Life Sciences N.V.Earnings Beat & Verified High Yield Trade Plans - Newser
What makes Atai Life Sciences N.V. stock price move sharplyJuly 2025 PostEarnings & Daily Price Action Insights - Newser
Does Atai Life Sciences N.V. fit your quant trading modelWeekly Gains Summary & Growth Focused Stock Reports - Newser
Is Atai Life Sciences N.V. stock entering bullish territoryJuly 2025 Sentiment & Weekly Breakout Stock Alerts - Newser
What recovery options are there for Atai Life Sciences N.V.Weekly Risk Summary & Proven Capital Preservation Tips - Newser
What data driven models say about Atai Life Sciences N.V.’s futureWeekly Trend Report & Community Trade Idea Sharing Platform - Newser
Predicting Atai Life Sciences N.V. trend using moving averages2025 Stock Rankings & Weekly Breakout Stock Alerts - Newser
Atai Life Sciences N.V.’s volatility index tracking explainedDollar Strength & High Yield Equity Trading Tips - Newser
Can Atai Life Sciences N.V. hit a new high this monthGold Moves & Capital Efficiency Focused Strategies - Newser
Why Atai Life Sciences N.V. stock attracts strong analyst attentionPortfolio Risk Report & Stepwise Entry and Exit Trade Signals - Newser
Institutional scanner results for Atai Life Sciences N.V.2025 Market Outlook & High Conviction Buy Zone Alerts - Newser
Volume spikes in Atai Life Sciences N.V. stock – what they meanFed Meeting & Real-Time Sentiment Analysis - Newser
Oppenheimer’s Price Target Raise Spurs Confidence in ATAI’s Growth Trajectory - timothysykes.com
Will Atai Life Sciences N.V. stock go up soonPortfolio Risk Summary & Free Growth Oriented Trading Recommendations - Newser
How to use Fibonacci retracement on Atai Life Sciences N.V.Fed Meeting & Real-Time Volume Analysis Alerts - Newser
Using Bollinger Bands to evaluate Atai Life Sciences N.V.Trade Risk Summary & High Accuracy Trade Alerts - Newser
Volatility clustering patterns for Atai Life Sciences N.V.2025 Earnings Impact & Weekly Top Gainers Trade List - Newser
When is the best time to exit Atai Life Sciences N.V.Price Action & Safe Investment Capital Preservation Plans - Newser
Will Atai Life Sciences N.V. see short term momentumJuly 2025 Catalysts & Reliable Momentum Entry Alerts - Newser
Atai Life Sciences Sees Strategic Gain Amid Positive Market Update - StocksToTrade
ATAI Life Sciences Gains Momentum Despite Mixed Phase 2 Data - timothysykes.com
Published on: 2025-08-21 01:29:25 - Newser
Does Atai Life Sciences N.V. qualify in momentum factor screeningQuarterly Investment Review & Capital Protection Trade Alerts - Newser
Is Atai Life Sciences N.V. trending in predictive chart modelsJuly 2025 PreEarnings & Risk Controlled Daily Plans - Newser
Apeiron Investment Group Buys 8.7M Shares in ATAI Life Sciences at $2.19/Share - AInvest
Here's Why atai Life Sciences (ATAI) Is a Great 'Buy the Bottom' Stock Now - Zacks Investment Research
What are Atai Life Sciences N.V.’s recent SEC filings showingTrade Entry Report & Low Risk Entry Point Guides - 선데이타임즈
Institutional Tools Highlight Unusual Flow in Atai Life Sciences N.V.Market Growth Review & Technical Confirmation Alerts - theviewers.co.kr
Is Atai Life Sciences N.V. forming a reversal pattern2025 Growth vs Value & AI Enhanced Trading Signals - Newser
Real time breakdown of Atai Life Sciences N.V. stock performance2025 Sector Review & Daily Chart Pattern Signal Reports - Newser
Is this a good reentry point in Atai Life Sciences N.V.2025 Geopolitical Influence & Accurate Buy Signal Alerts - Newser
Atai Life Sciences shares rise 1.50% premarket after reporting Q2 earnings results. - AInvest
Atai Life Sciences N.V. Nearing Breakout Level After BounceEarnings Miss & Daily Growth Stock Investment Tips - metal.it
Is Atai Life Sciences N.V. the Top Chart Pick This Week2025 Stock Rankings & AI Powered Market Entry Strategies - beatles.ru
Atai Life Sciences Reports Q2 2025 Financial Results - TipRanks
Atai Life Sciences shares fall 1.50% after-hours following earnings report. - AInvest
Atai Life Sciences N.V. Facing Inflection Point in Trend AnalysisVolume Spike & Safe Investment Capital Preservation Plans - newsyoung.net
Atai Life Sciences Revenue Jumps 163% - The Motley Fool
atai Life Sciences Reports Second Quarter 2025 Financial Results and Recent Corporate Updates - TradingView
Earnings Flash (ATAI) ATAI Life Sciences N.V. Reports Q2 Revenue $719,000 - MarketScreener
Earnings Flash (ATAI) Atai Life Sciences Posts Q2 Net Loss $0.14 a Share, vs. FactSet Est of $0.11 Loss - MarketScreener
Atai Life Sciences N.V. Bounces Off Moving Average SupportConservative Long Term Growth Plans Under Review - metal.it
Maxim Group Reiterates a Buy Rating on Atai Life Sciences (ATAI) With a $10 PT - Insider Monkey
How volatile is Atai Life Sciences N.V. stock compared to the marketAchieve consistent profits with expert advice - Jammu Links News
Atai Life Sciences N.V. Stock Analysis and ForecastFree Stock Market Return Analysis - Jammu Links News
What are analysts’ price targets for Atai Life Sciences N.V. in the next 12 monthsBoost your returns with professional guidance - Jammu Links News
Atai Life Sciences N V Stock (ATAI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.95%
0.90%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):